Rexahn Pharmaceuticals (AMEX:RNN) shares plunged 29.03% to $0.335 in the early hour. The company announced that Teva Pharmaceutical Industries Ltd. will provide an additional funding to Rexahn pursuant to the terms of its agreements with that company. The clinical stage pharmaceutical company commercializing potential best-in-class oncology and central nervous system therapeutics stated that pursuant to the agreement, Teva will invest $750,000 to purchase Rexahn's common stock at 120% of closing price of common stock on the last trading day preceding the closing.
Additionally, the company announced the pricing of an underwritten public offering of 19,130,435 shares of its common stock and warrants exercisable for up to 10,521,739 additional shares at $0.33 per fixed combination of shares and warrants for gross proceeds of approximately $6.3 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company and excluding the exercise of any warrants and any exercise of the underwriters' over-allotment option.
Will RNN Move Higher After Todays Sudden Selling Activities? Dont Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=RNN
Hemispherx BioPharma, Inc(AMEX:HEB) shares gained 2.15% to $0.814 in the morning hour. The company recently posted its quarterly earnings. The company reported ($0.04) EPS for the quarter. The company is a specialty pharmaceutical engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.
How Should Investors Trade HEB After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=HEB
Inovio Pharmaceuticals (AMEX:INO) shares climbed 1.56% to $0.548. The company has tested multiple synthetic vaccine constructs for cytomegalovirus (CMV) which induced robust T cells in mice, demonstrating the potential for a SynCon DNA vaccine to treat this virus that causes infant death and congenital abnormalities, is associated with cerebral palsy and brain tumours, and is the most common viral infection in organ transplant recipients.
Get Free Special Trend Analysis On INO Here http://beststocksdaily.com/p2/index.php?company=INO
Vringo (AMEX:VRNG) shares climbed 0.85% to $3.57. Newly filed documents show that the US district court in Norfolk VA has entered the official judgment in favor of Vringo. This news development, which had been anticipated by investors, now confirms the 3.5 % running royalty and past damages from Sept 15, 2011.
The company also reported a net loss for the third quarter of $3.1 million, mainly attributable to a non-operating income of $7.2 million. Total revenue for the third quarter was $266,000.
Get Free Special Trend Analysis On VRNG Here http://beststocksdaily.com/p2/index.php?company=VRNG
North American Palladium Ltd (USA)(AMEX:PAL) stock gained 2.67% to $1.54. The company entered into an agreement with an underwriter under which they have agreed to act as sole agent to sell 2,425,000 flow-through shares of NAP on a bought deal private placement basis, at a price of C$1.65 per Flow-Through Share (the "Offering"), for total proceeds of C$4,001,250.
Get Free Special Trend Analysis On PAL Here http://beststocksdaily.com/p2/index.php?company=PAL
Beststocksdailys team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdailys instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA